Legend Biotech says CARVYKTI posts about $710 million net trade sales in quarter ended Sept. 30, 2026
Legend Biotech flagged preliminary CARVYKTI net trade sales of about $710 million for the quarter ended Sept. 30, 2026. Figure was provided by partner Janssen; Legend Biotech has not independently verified the amount. No percentage changes were disclosed in the update. Disclaimer: This news brief was created by Public